No Data
No Data
Study in The Lancet Links Increased Meat Consumption to Higher Risk of Type 2 Diabetes, Highlighting 15% Risk Increase From Processed Meat and 10% From Unprocessed Red Meat; Beyond Meat Offers ADA-Certified Plant-Based Alternatives- Beyond Meat
BTIG Maintains Beyond Meat(BYND.US) With Hold Rating
BTIG analyst Peter Saleh maintains $Beyond Meat(BYND.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 61.2% and a total average return of 10.8% over the past year.
Beyond Meat (BYND) Receives a Hold From BTIG
Mizuho Securities Maintains Beyond Meat(BYND.US) With Sell Rating, Maintains Target Price $5
Mizuho Securities analyst John Baumgartner maintains $Beyond Meat(BYND.US)$ with a sell rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 65.7%
Aiming at the "healthy" track! Beyond Meat (BYND.US) will launch a new artificial steak product.
Beyond Meat will launch a beef steak alternative made entirely of plant-based muscle, as part of its global strategy to attract health-conscious consumers.
'Beyond Meat to Launch New Steak Alternative as It Focuses on Health' - CNBC